Epitomics approach for ovarian cancer biomarkers in serum 262
Gene expression studies in ovarian cancer 263
HtrA1 as a biomarker of response to chemotherapy in ovarian cancer 263
Mutation of genes in ovarian cancer 264
Serum biomarkers of ovarian cancer prognosis 264
Serum albumin-associated peptides and proteins 264
Multiplex assays for biomarkers of ovarian cancer 265
Concluding remarks on biomarker-based tests of ovarian cancer 266
Pancreatic cancer biomarkers 266
Discovery and validation of pancreatic cancer biomarkers 267
Cancer stem cells as biomarkers of pancreatic cancer 267
Histone modifications used as biomarkers in pancreatic cancer 267
miRNA biomarkers of pancreatic cancer 268
Proteomic biomarkers of pancreatic cancer 269
Prostate cancer 270
Adipose tissue-derived biomarkers of obesity-related prostate cancer 270
B7-H3 as biomarker of prostate cancer 271
Detection of prostate cancer biomarkers in urine 271
Detection of prostatic intraepithelial neoplasia 272
Epigenetic biomarkers of prostate cancer 272
Gene expression analysis of prostate cancer 273
Genetic biomarkers of prostate cancer 273
Huntingtin Interacting Protein 1 overexpression in prostate cancer 274
Id proteins expression in prostate cancer 274
Identification of prostate cancer mRNA biomarkers 274
Integrative genomic and proteomic profiling of prostate cancer 274
LCM for diagnosis of prostate cancer 275
Loss of p27 as predictor of recurrence of prostate cancer 275
Microarray for diagnosis of prostate cancer 275
miRNA biomarkers of prostate cancer 276
Prostate cancer biomarkers in semen 276
PSA as biomarker of prostate cancer 276
ProPSA as biomarker of prostate cancer 277
Prostate Health Index 277
PSMA as biomarker of prostate cancer 277
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |